Protein Need and Interest of " Quick Proteins " to the Obese Subject Operated by Bariatric Surgery (BIBOP)
NCT ID: NCT01249326
Last Updated: 2018-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2010-12-31
2015-03-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Protein Supplementation Post Bariatric Surgery
NCT02951663
Protein Requirements After Bariatric Surgery
NCT06853652
NUTritional Impact of a Hypocaloric Hyperprotein Diet Before Obesity Surgery
NCT04942093
Evaluation of the Implementation of a Diet Workshop on the 15th Postoperative Day Following Bariatric Surgery
NCT05695040
Study of Bariatric Surgery
NCT02857179
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bariatric surgery
This is a prospective longitudinal study of the effect of bariatric surgery on protein requirements and protein metabolism, and protein supplementation interest, appropriate to the digestive tract changes, for the mass and muscle function
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 to 60 years.
* Body mass index: BMI\> 40 kg/m2,
* Biological Review considered satisfactory by the investigator based on the topics covered
* Serology HIV ( Human Immunodeficiency Virus )and HCV (Hepatitis C Virus ) negative.
* Subject giving his written informed consent
* Affiliated to National Health Insurance
Exclusion Criteria
* Balance Organic considered abnormal by the investigator.
* Serology HIV or HCV positive.
* Pregnant or lactating.
* For women of childbearing age: β-HCG assay positive and not having reliable contraceptives (oral contraceptive, IUD (Intrauterine Device), implant or hormone patch, abstinence).
* Medical or surgical history (judged by investigator to be incompatible with the study).
* Subject with unstable psychiatric condition
* Blood donation in the two months preceding the study.
* Heavy alcohol consumption (\> 2 to 3 glasses per day depending on sex) or presence of an addiction.
* Tobacco significant (\> 5 cigarettes / day or equivalent in cigars or pipe tobacco).
* Subjects with an allergy or intolerance to dairy products.
* Intense sporting activity (\> 5 hours / week).
* Being in exclusion on the National Volonteers Data file or having perceived more than 4500 Euros in the year for clinical study participation.
* No one under guardianship or not subject to social security.
* Subjects deprived of their liberty by judicial or administrative decision.
* Refusal to sign the information sheet and written consent for participation
* Subject with a cardiovascular or neoplasic evolutive disease
* Subject with a severe infection in the 3 months period before inclusion (assessed by doctor during inclusion consultation)
* Hypercorticism and dysthyroïdism
* Subject with a known neuro-muscular disease
* Subject with a chronic or acute inflammatory disease in the 3 months period before inclusion
* Subject treated by: corticoids, immunosupressor, anabolic agents, growth factor or having stopped treatment for less than 3 months before inclusion.
Furthermore for subjects having undergone a by-pass at Lyon:
* Subject consuming pre or probiotics many times per day, having an impact on intestinal flora.
* Subject with antibiotics during the 3 months before the beginning of the study.
* Subject with an intolerance to dairy products and refusing to consume dairy prod
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre de Recherche en Nutrition Humaine d'Auvergne
OTHER_GOV
Centre de Recherche en Nutrition Humaine Rhone-Alpe
OTHER
Hospices Civils de Lyon
OTHER
Service de médecine du Sport et des Explorations Fonctionnelles - CHRU de Clermont-Ferrand
UNKNOWN
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yves BOIRIE
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Clermont-Ferrand
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Guillet C, Masgrau A, Mishellany-Dutour A, Blot A, Caille A, Lyon N, Pereira B, Slim K, Robert M, Disse E, Feugier N, Le Ruyet P, Louvet C, Miolanne M, Farigon N, Laville M, Boirie Y. Bariatric surgery affects obesity-related protein requirements. Clin Nutr ESPEN. 2020 Dec;40:392-400. doi: 10.1016/j.clnesp.2020.06.007. Epub 2020 Oct 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009-A01093-54
Identifier Type: REGISTRY
Identifier Source: secondary_id
CHU-0084
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.